F65-36681-88764
2 vaccinations
10 coded responses
18 check-ins
10 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 288 / NC
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
BQF-21495-54464
Child or adolescent in my care · Male · 2021-11-06
Timeline
-
2021-03-17
Dose 1 — Moderna
-
2021-03-22
Registered in v-safe
-
2021-03-24
Survey response — day 7, dose 1MedDRA: Diplopia, Migraine — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Migraine and double visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — day 14, dose 1MedDRA: Balance disorder, Headache, Hidradenitis, Migraine, Pre-existing disease, Rheumatoid arthritis — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Continued migraine symptoms--severe headache and some balance issues.Marked flareup in symptoms of RA and a hidradenitis suppurativa.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-09
Survey response — day 21, dose 1MedDRA: Crohn's disease, Pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased Crohn's fistula activity resulting in substantial pain when sitting or walkingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
- 2021-04-21
-
2021-04-27
Dose 2 — Moderna
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): I had unrelated surgery today · Healthcare visit (other): Outpatient surgery for prior conditionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-04
Survey response — day 7, dose 2MedDRA: Unevaluable event — Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Recovering from unrelated surgeryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-11
- 2021-05-18
-
2021-05-25
Survey response — day 28, dose 2MedDRA: Seasonal allergy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Severe seasonal allergy symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-01
Survey response — day 35, dose 2MedDRA: Cough, Nasal congestion — Feeling: GoodFree text: Coughing and stuffy noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-08
Survey response — day 42, dose 2MedDRA: Pre-existing disease, Rheumatoid arthritis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Rheumatoid arthritis symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-29
-
2021-10-26
Survey response — 6 months, dose 2MedDRA: Eye inflammation, Visual impairment — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Eye inflammation causing vision changesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-28
-
2022-04-27
Survey response — 12 months, dose 2MedDRA: Inflammation, Pre-existing disease, Rheumatoid arthritis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Increased RA inflammationMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-28
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Moderna | |
| 2 | 2021-04-27 | Moderna |
Call center
4 call center cases
4 successful
VAERS report filed, before or during a call: 1
Free text
Release 6 — day 7, dose 1
Systemic reaction (other): Migraine and double vision
Release 6 — day 14, dose 1
Symptoms: Continued migraine symptoms--severe headache and some balance issues.Marked flareup in symptoms of RA and a hidradenitis suppurativa.
Release 7 — day 21, dose 1
Symptoms: Increased Crohn's fistula activity resulting in substantial pain when sitting or walking
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): I had unrelated surgery today
Healthcare visit (other): Outpatient surgery for prior condition
Release 8 — day 7, dose 2
Systemic reaction (other): Recovering from unrelated surgery
Release 8 — day 28, dose 2
Symptoms: Severe seasonal allergy symptoms
Release 8 — day 35, dose 2
Symptoms: Coughing and stuffy nose
Release 8 — day 42, dose 2
Symptoms: Rheumatoid arthritis symptoms
Release 10 — 6 months, dose 2
Symptoms: Eye inflammation causing vision changes
Release 11 — 12 months, dose 2
Symptoms: Increased RA inflammation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Balance disorder | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Crohn's disease | ✓ | ✓ | ✓ |
| SD | Eye inflammation | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hidradenitis | ✓ | ✓ | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rheumatoid arthritis | ✓ | ✓ | ✓ |
| SD | Seasonal allergy | ✓ | ✓ | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Diplopia | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release